Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 79645-27-5
2. Tobramycin (sulfate)
3. 4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol Sulfate
4. Nebramycin Factor 6 (sulfate);deoxykanamycin B (sulfate)
5. 1294492-03-7
6. Hms3371o08
7. Bcp12890
8. Akos015895163
9. Ac-4512
10. Ft-0652844
11. 4-amino-2-[4,6-diamino-3-[3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric Acid
Molecular Weight | 565.6 g/mol |
---|---|
Molecular Formula | C18H39N5O13S |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 6 |
Exact Mass | 565.22650749 g/mol |
Monoisotopic Mass | 565.22650749 g/mol |
Topological Polar Surface Area | 351 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 691 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 14 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-12-09
Pay. Date : 2014-06-23
DMF Number : 27841
Submission : 2013-12-23
Status : Active
Type : II
NDC Package Code : 42513-0009
Start Marketing Date : 2020-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13513
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16810
Submission : 2003-08-20
Status : Inactive
Type : II
Registration Number : 228MF10200
Registrant's Address : Dalslandsgade 11, DK-2300 Copenhagen-S, Denmark
Initial Date of Registration : 2016-10-21
Latest Date of Registration :
NDC Package Code : 45932-0012
Start Marketing Date : 2000-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17109
Submission : 2004-01-20
Status : Inactive
Type : II
Registrant Name : Daebong LS Co., Ltd.
Registration Date : 2020-07-16
Registration Number : 20200716-91-E-166-06
Manufacturer Name : Daebong LS Co., Ltd @ [Tobramycin Manufacturing Plant] Livzon New North River Pharmaceutical Co., Ltd
Manufacturer Address : 123, Neungheodae-ro 649beon-gil, Namdong-gu, Incheon Metropolitan City @ [Tobramycin Manufacturing Plant] Renmin One Road, Qingyuan, Guangdong Province, PR China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13513
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17109
Submission : 2004-01-20
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-12-09
Pay. Date : 2014-06-23
DMF Number : 27841
Submission : 2013-12-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16810
Submission : 2003-08-20
Status : Inactive
Type : II
Registration Number : 228MF10200
Registrant's Address : Dalslandsgade 11, DK-2300 Copenhagen-S, Denmark
Initial Date of Registration : 2016-10-21
Latest Date of Registration : 2016-10-21
Registrant Name : Daebong LS Co., Ltd.
Registration Date : 2020-07-16
Registration Number : 20200716-91-E-166-06
Manufacturer Name : Daebong LS Co., Ltd @ [Tobra...
Manufacturer Address : 123, Neungheodae-ro 649beon-gil, Namdong-gu, Incheon Metropolitan City @ [Tobramycin ...
NDC Package Code : 62991-1351
Start Marketing Date : 2011-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 42513-0009
Start Marketing Date : 2020-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42513-0009
Start Marketing Date : 2014-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0319
Start Marketing Date : 2014-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63552-025
Start Marketing Date : 2001-08-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1.2g/30mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49452-7821
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-008
Start Marketing Date : 2016-03-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (7kg/7kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45932-0012
Start Marketing Date : 2000-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45932-0014
Start Marketing Date : 2000-09-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Arihantanam Life Care Pvt. Ltd. is engaged in Manufacturing of Various Active Pharmaceuticals Ingredients Since 2006. We are a WHO-GMP approved facility and have installed moder...
About the Company : Fujian Fukang Pharmaceutical Co., Ltd (Fukang) is located in Fuzhou-capital of Fujian province, founded in 1958, renamed Fuzhou Antibiotic General Factory in 1992 and became a whol...
About the Company : Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd(FFPC),a subsidiary of Livzon Pharmaceutical Group Inc.,was founded in 1989 as a state-owned company.Now Livzon Fuxing has become a...
About the Company : Established in the year 2002, we are known to be a well established Exporter, Manufacturer and Supplier in India. Being a quality centric firm, we are committed to offer a range Ac...
About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...
About the Company : Tocopharm Co. Limited, built in 2008,is an industry leader in the field of Active Pharmaceutical Ingredients(API), relative pharmaceutical intermediates, derivatives of Quinoline d...
About the Company : Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing clinically effective anti-infective treatments against serious and often life-threatening infectio...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Global Sales Information
Market Place
ABOUT THIS PAGE
63
PharmaCompass offers a list of Tobramycin Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tobramycin Sulfate manufacturer or Tobramycin Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tobramycin Sulfate manufacturer or Tobramycin Sulfate supplier.
PharmaCompass also assists you with knowing the Tobramycin Sulfate API Price utilized in the formulation of products. Tobramycin Sulfate API Price is not always fixed or binding as the Tobramycin Sulfate Price is obtained through a variety of data sources. The Tobramycin Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tobramycin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tobramycin Sulfate, including repackagers and relabelers. The FDA regulates Tobramycin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tobramycin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tobramycin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tobramycin Sulfate supplier is an individual or a company that provides Tobramycin Sulfate active pharmaceutical ingredient (API) or Tobramycin Sulfate finished formulations upon request. The Tobramycin Sulfate suppliers may include Tobramycin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Tobramycin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tobramycin Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tobramycin Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Tobramycin Sulfate DMFs exist exist since differing nations have different regulations, such as Tobramycin Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tobramycin Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Tobramycin Sulfate USDMF includes data on Tobramycin Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tobramycin Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tobramycin Sulfate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tobramycin Sulfate Drug Master File in Japan (Tobramycin Sulfate JDMF) empowers Tobramycin Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tobramycin Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Tobramycin Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tobramycin Sulfate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tobramycin Sulfate Drug Master File in Korea (Tobramycin Sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tobramycin Sulfate. The MFDS reviews the Tobramycin Sulfate KDMF as part of the drug registration process and uses the information provided in the Tobramycin Sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tobramycin Sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tobramycin Sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tobramycin Sulfate suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tobramycin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tobramycin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tobramycin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tobramycin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tobramycin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tobramycin Sulfate suppliers with NDC on PharmaCompass.
Tobramycin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tobramycin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tobramycin Sulfate GMP manufacturer or Tobramycin Sulfate GMP API supplier for your needs.
A Tobramycin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Tobramycin Sulfate's compliance with Tobramycin Sulfate specifications and serves as a tool for batch-level quality control.
Tobramycin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Tobramycin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tobramycin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tobramycin Sulfate EP), Tobramycin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tobramycin Sulfate USP).